1. Home
  2. OMER
  3. OMER News

Latest Omeros Corporation (OMER) News on November 18, 2025

Omeros Corp (OMER) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges
OMER

GuruFocus.com

4 days ago

Omeros Corp (OMER) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges

OMER

Associated Press Finance

5 days ago

Omeros: Q3 Earnings Snapshot

Omeros Corporation Reports Third Quarter 2025 Financial Results
OMER

Business Wire

5 days ago

Omeros Corporation Reports Third Quarter 2025 Financial Results

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
OMER

Business Wire

7 days ago

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025

Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues
OMER

GlobeNewswire

13 days ago

Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues

Is Omeros Corporation (OMER) One of the Hot Stocks to Buy with Huge Upside Potential?
OMER

Insider Monkey

23 days ago

Is Omeros Corporation (OMER) One of the Hot Stocks to Buy with Huge Upside Potential?

J.P. Morgan Maintains a Buy on Novo Nordisk (NVO)
OMER

Insider Monkey

a month ago

J.P. Morgan Maintains a Buy on Novo Nordisk (NVO)

Complement 3 Glomerulopathy Market Poised for Phenomenal Expansion at a CAGR of 37.2% During the Forecast Period (2025–2034) Owing to the Launch of Promising Therapies Targeting C3, C5, MASP-3, and RNAi | DelveInsight
OMER

GlobeNewswire

a month ago

Complement 3 Glomerulopathy Market Poised for Phenomenal Expansion at a CAGR of 37.2% During the Forecast Period (2025–2034) Owing to the Launch of Promising Therapies Targeting C3, C5, MASP-3, and RNAi | DelveInsight

Omeros Sells Exclusive Global Rights for Drug Zaltenibart to Novo Nordisk
OMER

Insider Monkey

a month ago

Omeros Sells Exclusive Global Rights for Drug Zaltenibart to Novo Nordisk

Can Novo Nordisk’s (CPSE:NOVO B) Rare Disease Deal Reshape Its Long-Term Growth Story?
OMER

Simply Wall St.

a month ago

Can Novo Nordisk’s (CPSE:NOVO B) Rare Disease Deal Reshape Its Long-Term Growth Story?

Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn
OMER

Pharmaceutical Technology

a month ago

Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn

NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio
OMER

Zacks

a month ago

NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio

Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group
OMER

Business Wire

a month ago

Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group

A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
OMER

Motley Fool

a month ago

A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?

Omeros Catapults 154% On A Surprise $2.1 Billion Deal With Novo Nordisk
OMER

Investor's Business Daily

a month ago

Omeros Catapults 154% On A Surprise $2.1 Billion Deal With Novo Nordisk

Novo Nordisk Just Signed a Key Drug Deal With Omeros. Is There Any Room Left for OMER Stock to Run?
OMER

Barchart

a month ago

Novo Nordisk Just Signed a Key Drug Deal With Omeros. Is There Any Room Left for OMER Stock to Run?

OMER

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Late Afternoon

OMER

MT Newswires

5 months ago

Omeros Seeks European Medicine Agency nod for Narsoplimab

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA
OMER

Business Wire

5 months ago

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA

Omeros Announces Webcast Details for Annual Meeting of Shareholders
OMER

Business Wire

5 months ago

Omeros Announces Webcast Details for Annual Meeting of Shareholders

OMER

MT Newswires

5 months ago

HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target

Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER)
OMER

Zacks

5 months ago

Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER)

OMER

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Omeros Corp Earnings Call

Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ...
OMER

GuruFocus.com

6 months ago

Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ...

OMER

Associated Press Finance

6 months ago

Omeros: Q1 Earnings Snapshot

Omeros Corporation Reports First Quarter 2025 Financial Results
OMER

Business Wire

6 months ago

Omeros Corporation Reports First Quarter 2025 Financial Results

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025
OMER

Business Wire

6 months ago

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025

OMER

MT Newswires

6 months ago

Top Midday Decliners

OMER

MT Newswires

6 months ago

Omeros to Exchange 2026 Convertible Notes for New 2029 Notes

Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
OMER

Business Wire

6 months ago

Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026

FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date
OMER

Business Wire

6 months ago

FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program
OMER

Business Wire

7 months ago

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program

Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases
OMER

Business Wire

7 months ago

Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases

OMER

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Omeros Corp Earnings Call

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
OMER

GuruFocus.com

8 months ago

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ...

OMER

Associated Press Finance

8 months ago

Omeros: Q4 Earnings Snapshot

Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results
OMER

Business Wire

8 months ago

Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results

Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025
OMER

Business Wire

8 months ago

Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025

Omeros to activate site for Phase III programme of zaltenibart for PNH
OMER

Clinical Trials Arena

8 months ago

Omeros to activate site for Phase III programme of zaltenibart for PNH

OMER

MT Newswires

8 months ago

Omeros Says Trial Site Activation Underway for Phase 3 Study of Zaltenibart

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program
OMER

Business Wire

8 months ago

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program

Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company’s OMS527 Program to Treat Cocaine Use Disorder
OMER

Business Wire

8 months ago

Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company’s OMS527 Program to Treat Cocaine Use Disorder

Omeros announces results for narsoplimab expanded access program
OMER

TipRanks

9 months ago

Omeros announces results for narsoplimab expanded access program

Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
OMER

Business Wire

9 months ago

Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA

Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
OMER

Business Wire

9 months ago

Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings

Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
OMER

Business Wire

9 months ago

Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program

Institutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the company
OMER

Simply Wall St.

9 months ago

Institutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the company

OMER

MT Newswires

10 months ago

New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results

Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
OMER

Business Wire

10 months ago

Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint

When Can We Expect A Profit From Omeros Corporation (NASDAQ:OMER)?
OMER

Simply Wall St.

a year ago

When Can We Expect A Profit From Omeros Corporation (NASDAQ:OMER)?

OMER

MT Newswires

a year ago

Sector Update: Health Care Stocks Lower Thursday Afternoon

OMER

MT Newswires

a year ago

Top Midday Gainers

Omeros Reports Narsoplimab TA-TMA Trial Success; Stock Surges
OMER

GuruFocus.com

a year ago

Omeros Reports Narsoplimab TA-TMA Trial Success; Stock Surges

OMER

MT Newswires

a year ago

Omeros' Pivotal Trial of Narsoplimab Meets Primary Endpoint

Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA
OMER

Business Wire

a year ago

Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA

Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges
OMER

Insider Monkey

a year ago

Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges

Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
OMER

Business Wire

a year ago

Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting

Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
OMER

Business Wire

a year ago

Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting

Omeros Updates Progress on Narsoplimab Biologics License Resubmission; Stock up Over 30% on News
OMER

GuruFocus.com

a year ago

Omeros Updates Progress on Narsoplimab Biologics License Resubmission; Stock up Over 30% on News

Omeros Corporation Provides Update on Progress Toward BLA Resubmission
OMER

Business Wire

a year ago

Omeros Corporation Provides Update on Progress Toward BLA Resubmission

OMER

Thomson Reuters StreetEvents

a year ago

Q3 2024 Omeros Corp Earnings Call

Omeros Corp (OMER) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Adjustments
OMER

GuruFocus.com

a year ago

Omeros Corp (OMER) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Adjustments

OMER

Associated Press Finance

a year ago

Omeros: Q3 Earnings Snapshot

Omeros Corporation Reports Third Quarter 2024 Financial Results
OMER

Business Wire

a year ago

Omeros Corporation Reports Third Quarter 2024 Financial Results

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
OMER

Business Wire

a year ago

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024

OMER

MT Newswires

a year ago

Omeros Gets FDA Rare Pediatric Disease Designation for Kidney Disease Drug Candidate

Retail investors account for 52% of Omeros Corporation's (NASDAQ:OMER) ownership, while institutions account for 43%
OMER

Simply Wall St.

a year ago

Retail investors account for 52% of Omeros Corporation's (NASDAQ:OMER) ownership, while institutions account for 43%

OMER

Associated Press Finance

a year ago

Omeros: Q2 Earnings Snapshot

Omeros Corporation Reports Second Quarter 2024 Financial Results
OMER

Business Wire

a year ago

Omeros Corporation Reports Second Quarter 2024 Financial Results

Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
OMER

Business Wire

a year ago

Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024

Edge Total Intelligence Inc. Updates Status of MCTO
OMER

Newsfile

a year ago

Edge Total Intelligence Inc. Updates Status of MCTO

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
OMER

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
OMER

GlobeNewswire

a year ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
OMER

GlobeNewswire

a year ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
OMER

GlobeNewswire

a year ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
OMER

GlobeNewswire

a year ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
OMER

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
OMER

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Omeros Announces Webcast Details for Annual Meeting of Shareholders
OMER

Business Wire

a year ago

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
OMER

Business Wire

a year ago

Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028

OMER

Thomson Reuters StreetEvents

2 years ago

Q1 2024 Omeros Corp Earnings Call

OMER

GuruFocus.com

2 years ago

Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...

OMER

Associated Press Finance

2 years ago

Omeros: Q1 Earnings Snapshot

Omeros Corporation Reports First Quarter 2024 Financial Results
OMER

Business Wire

2 years ago

Omeros Corporation Reports First Quarter 2024 Financial Results

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
OMER

Business Wire

2 years ago

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024

Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
OMER

Business Wire

2 years ago

Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress

OMER

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Omeros Corp Earnings Call

Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript
OMER

Insider Monkey

2 years ago

Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript

OMER

GuruFocus.com

2 years ago

Omeros Corp (OMER) Reports Fourth Quarter and Year-End 2023 Financial Results

OMER

Associated Press Finance

2 years ago

Omeros: Q4 Earnings Snapshot

Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
OMER

Business Wire

2 years ago

Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results

Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
OMER

Business Wire

2 years ago

Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
OMER

Business Wire

2 years ago

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

3 Sleeper Stocks Under $15 Ready to Explode by 2029
OMER

InvestorPlace

2 years ago

3 Sleeper Stocks Under $15 Ready to Explode by 2029

Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
OMER

Business Wire

2 years ago

Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust

3 Basic Materials Stocks to Sell as the Commodity Cycle Turns in 2024
OMER

InvestorPlace

2 years ago

3 Basic Materials Stocks to Sell as the Commodity Cycle Turns in 2024

Abbott (ABT) Q4 Earnings Match Estimates
OMER

Zacks

2 years ago

Abbott (ABT) Q4 Earnings Match Estimates

OMER

Business Wire

2 years ago

Xperi Launches First UK In-Car Entertainment Report, Consumers Call for a Personalised Entertainment Dash

Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most
OMER

Simply Wall St.

2 years ago

Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most

Favourable Signals For Hamilton Beach Brands Holding: Numerous Insiders Acquired Stock
OMER

Simply Wall St.

2 years ago

Favourable Signals For Hamilton Beach Brands Holding: Numerous Insiders Acquired Stock

Share on Social Networks: